BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38370352)

  • 21. Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.
    Gonnissen A; Isebaert S; Perneel C; McKee CM; Van Utterbeeck F; Lerut E; Verrill C; Bryant RJ; Joniau S; Muschel RJ; Haustermans K
    Am J Pathol; 2018 Mar; 188(3):795-804. PubMed ID: 29339090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma.
    Ishikawa M; Sonobe M; Imamura N; Sowa T; Shikuma K; Date H
    World J Surg Oncol; 2014 Aug; 12():253. PubMed ID: 25103784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carnosol inhibits Hedgehog signaling pathway in both LNCaP and DU145 prostate cancer cell lines.
    Gao H; Song Q; Yang J; Yu S; Zhao J; Yu G
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):104-108. PubMed ID: 28886322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
    Epstein JI; Zelefsky MJ; Sjoberg DD; Nelson JB; Egevad L; Magi-Galluzzi C; Vickers AJ; Parwani AV; Reuter VE; Fine SW; Eastham JA; Wiklund P; Han M; Reddy CA; Ciezki JP; Nyberg T; Klein EA
    Eur Urol; 2016 Mar; 69(3):428-35. PubMed ID: 26166626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
    Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
    Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive immunohistochemical analyses on expression levels of hedgehog signaling molecules in breast cancers.
    Kurebayashi J; Kanomata N; Koike Y; Ohta Y; Saitoh W; Kishino E
    Breast Cancer; 2018 Nov; 25(6):759-767. PubMed ID: 29946869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b.
    Karlou M; Lu JF; Wu G; Maity S; Tzelepi V; Navone NM; Hoang A; Logothetis CJ; Efstathiou E
    Prostate; 2012 Nov; 72(15):1638-47. PubMed ID: 22457212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome.
    He HC; Chen JH; Chen XB; Qin GQ; Cai C; Liang YX; Han ZD; Dai QS; Chen YR; Zeng GH; Zhu JG; Jiang FN; Zhong WD
    Pathol Oncol Res; 2012 Apr; 18(2):349-55. PubMed ID: 21861243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer.
    Singh SK; Gordetsky JB; Bae S; Acosta EP; Lillard JW; Singh R
    Cells; 2020 Aug; 9(9):. PubMed ID: 32867229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Proteome of Primary Prostate Cancer.
    Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
    Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy.
    Yoshikawa R; Nakano Y; Tao L; Koishi K; Matsumoto T; Sasako M; Tsujimura T; Hashimoto-Tamaoki T; Fujiwara Y
    Br J Cancer; 2008 May; 98(10):1670-4. PubMed ID: 18475300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway.
    Lu JT; Zhao WD; He W; Wei W
    Acta Pharmacol Sin; 2012 May; 33(5):691-700. PubMed ID: 22543708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
    Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
    Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options.
    Janiczek M; Szylberg Ł; Antosik P; Kasperska A; Marszałek A
    J Immunol Res; 2020; 2020():4910595. PubMed ID: 32537467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.
    Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M
    Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas.
    Gialmanidis IP; Bravou V; Amanetopoulou SG; Varakis J; Kourea H; Papadaki H
    Lung Cancer; 2009 Oct; 66(1):64-74. PubMed ID: 19200615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of activator proteins of SHH/GLI and PI3K/Akt/mTORC1 signaling pathways in human gliomas is associated with high grade tumors.
    Henao-Restrepo J; Caro-Urrego YA; Barrera-Arenas LM; Arango-Viana JC; Bermudez-Munoz M
    Exp Mol Pathol; 2021 Oct; 122():104673. PubMed ID: 34371011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables.
    Luo HJ; Luo P; Yang GL; Peng QL; Liu MR; Tu G
    J Breast Cancer; 2011 Sep; 14(3):185-90. PubMed ID: 22031799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
    Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation of the expressions of 4-HNE and GPC5 with the progression of prostate cancer].
    Song Q; Yan HZ; Wang R; Zhang ZY; Zuo QJ; Song X
    Zhonghua Nan Ke Xue; 2023 Jan; 29(1):19-24. PubMed ID: 37846827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.